Heartland Advisors has picked up 88,747 additional shares of Invacare stock, the firm disclosed in a report filed with the SEC on May 3. Heartland Advisors now holds about 3.6 million shares valued at about $39.95 million.
SAN DIEGO – Peter Farrell, founder and chairman of ResMed, sold 20,000 shares of company stock valued at $1.04 million in a transaction on Jan. 4. Farrell still owns 347,978 shares in the company, valued at $18.2 million.
GOLETA, Calif. – Two Inogen shareholders have moved stock this month. Scott Wilkinson sold 15,735 shares on Dec. 29 at an average price of $30.52 per share for a total transaction of $480,232. Versant Ventures sold 9,785 shares on Dec.
NEW YORK – Inogen Director Timothy Petersen sold 46,865 shares on Sept. 22 in a transaction worth nearly $1 million. The shares sold at an average price of $21.05 for a total of $986,508. Peterson previously sold 39,135 shares on Sept.
SAN DIEGO – Peter Farrell, the former CEO of ResMed and a current director, sold 25,000 shares of company stock on the open market in a transaction dated May 1. The stock was sold at $49.80 for a total value of $1.245 million.
GOLETA, Calif. – Inogen (INGN) opened for trading on the NASDAQ on Feb. 14, pricing about 4.4 million shares of its stock at $16 per share, the low end of an expected range of $16 to $18. On Feb. 18, the company’s stock was trading at $15.28 per share.